Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Share Option Schemes

4 Oct 2010 11:58

RNS Number : 7994T
Imaginatik PLC
04 October 2010
 



4 October 2010

Imaginatik Plc

("Imaginatik" or the "Company")

Share Option Schemes

 

Imaginatik plc (AIM:IMTK), a leading provider of idea management software and innovation consultancy, announces that on 30 September 2010, the remuneration committee of the Board approved the issue of share options to all employees, including directors, and also approved the re-basing of the exercise price of all subsisting share options in issue at that date, to 2.55p per share. This provides both the senior management team and employees an appropriate and effective incentive for the future.

 

The Company has two share option schemes in place. The Imaginatik Plc Enterprise Management Incentive Scheme (the "Share Option Scheme") and the Imaginatik 2006 Stock Option Plan (the "Stock Option Plan"). There are 17,695,882 share options over ordinary shares of 0.0625p each outstanding under the Share Option Scheme and 8,050,000 share options over ordinary shares of 0.0625p each outstanding under the Stock Option Plan. In addition, there are 4,693,463 share options outstanding under the unapproved share option scheme.

 

No other changes to the share option deeds, dated 11 December 2006, have been made.

 

Options have also been granted to the following directors of the Company, these options are included in the outstanding options noted above:

 

 

Director

Options granted

Total number of share options

Matt Cooper

2,125,000

3,125,000

Shawn Taylor

1,700,000

6,200,000

Andrew Wainwright

1,500,000

3,750,000

 

All the Options have been granted at an exercise price of 2.55 pence per share and are exercisable from 30 September 2012 to 30 September 2013.

 

Matt Cooper, Executive Chairman commented,"It remains the view of the Board that the rebasing of the share options to this level represents the best means by which we can ensure that all of our talented employees remain well incentivised. Share options are a crucial tool in the motivation of all of our employees, furthermore I believe that the shareholders will enjoy benefits earlier if all of our personnel have a more achievable interest in the success of the business"

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

 

For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEIIDLSIII
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.